pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
nerinetide
Acute Ischemic Stroke
NoNO Inc
0 catalysts
Phase 2
nesuparib
nesuparib [INN]
Pancreatic Ductal Adenocarcinoma
Onconic Therapeutics Co Ltd
0 catalysts
Phase 2
nesvategrast
nesvategrast [INN]
Diabetic Macular Edema
OcuTerra Therapeutics Inc
0 catalysts
Marketed
← prev
page 199 of 231
next →
131
Pain89
Neurology1
netarsudil mesylate
Rhopressa (netarsudil mesylate)
Ocular Hypertension
$ALCALCON INC
0 catalysts
Marketed
nevirapine
Nevirapine (nevirapine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Camber Pharmaceuticals Inc
0 catalysts
Phase 3
nexiguran ziclumeran
Familial Amyloid Cardiomyopathy
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
niacin
Niacor (niacin)
Cardiovascular Risk Factors
Avondale Pharmaceuticals LLC
0 catalysts
Phase 3
nibrozetone
Small-Cell Lung Cancer
EpicentRx Inc
0 catalysts
Preclinical
niclosamide
Hearing Disorders
Ting Therapeutics LLC
0 catalysts
Phase 1
nicorandil ER
nicorandil
Chronic Stable Angina
Auxilius Pharma
0 catalysts
Marketed
nicotine ER
Nicotine (nicotine)
Smoking Cessation
AVEVA Drug Delivery Systems Inc
0 catalysts
Marketed
nicotine bitartrate
Nicotrol (nicotine bitartrate)
Smoking Cessation
$PFEPFIZER INC
0 catalysts
Marketed
nicotine polacrilex
Nicotine Polacrilex (nicotine polacrilex)
Smoking Cessation
PL Developments Copiague LLC
0 catalysts
Marketed
nifedipine
Nifedipine (nifedipine)
Hypertension
Acella Pharmaceuticals LLC
0 catalysts
Marketed
nifurtimox
Lampit (nifurtimox [INN])
Chagas Disease (American Trypanosomiasis)
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
Marketed
nilutamide
Nilutamide Prasco (nilutamide)
Metastatic Prostate Cancer
Prasco LLC
0 catalysts
Phase 2
nimacimab
Obesity
Cannabinoid receptor 1
$SKYESkye Bioscience, Inc.
0 catalysts
Marketed
nimodipine
Nimodipine (nimodipine)
Subarachnoid Hemorrhage
Mineralocorticoid receptorVoltage-gated L-type calcium channel
$GRCEGrace Therapeutics, Inc.
0 catalysts
Phase 2
ninsipapogene sibarnarepvec
Head And Neck Squamous Cell Carcinoma (HNSC)
$HOOKHOOKIPA Pharma Inc.
0 catalysts
Phase 3
nintedanib
NINTEDANIB (nintedanib)
Pterygium
Platelet-derived growth factor receptorVascular endothelial growth factor receptor
Cloudbreak Therapeutics LLC
0 catalysts
pre_registration
nipocalimab
Imaavy (nipocalimab-aahu)
Acquired (Autoimmune) Hemolytic Anemia
$JNJJOHNSON & JOHNSON
0 catalysts
pre_registration
nirmatrelvir + ritonavir
Paxlovid (nirmatrelvir + ritonavir)
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Phase 2
nispomeben
nispomeben [INN]
Diabetic Neuropathic Pain
Novaremed AG
0 catalysts
Phase 1
nitazoxanide
Alinia (nitazoxanide)
Acute On Chronic Liver Failure (ACLF)
Genfit SA
0 catalysts
Marketed
nitisinone
Orfadin (nitisinone)
Tyrosinemia
Sobi Inc
0 catalysts
Marketed
nitric oxide
Noxivent (nitric oxide)
Hypoxemic Respiratory Failure (Type I)
$LINLINDE PLC
0 catalysts
Marketed
nitrofurantoin
Nitrofurantoin (nitrofurantoin)
Urinary Tract Infections
Creekwood Pharmaceutical Inc
0 catalysts
Marketed
nitrous oxide
Nitrous Oxide (nitrous oxide)
Local Anesthetic Effect
Matheson Tri-Gas Inc
0 catalysts
Phase 2
nitroxoline
nitroxoline [INN]
Muscle Invasive Bladder Cancer (MIBC)
Asieris Pharmaceuticals (USA) Inc
0 catalysts
Phase 2
nivisnebart
Alzheimer's Disease
$ALECAlector, Inc.
0 catalysts